Shares of Extendicare Inc. (TSE:EXE – Get Free Report) hit a new 52-week high during trading on Tuesday . The stock traded as high as C$11.77 and last traded at C$11.67, with a volume of 49144 shares trading hands. The stock had previously closed at C$11.54.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on EXE. BMO Capital Markets set a C$11.00 target price on shares of Extendicare and gave the stock a “market perform” rating in a report on Thursday, January 30th. Cormark upgraded shares of Extendicare to a “moderate buy” rating in a report on Wednesday, February 19th. TD Securities increased their target price on Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research note on Thursday, November 14th. Finally, Royal Bank of Canada lifted their target price on Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a report on Thursday, November 28th. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of C$10.25.
View Our Latest Report on Extendicare
Extendicare Stock Down 0.1 %
Extendicare Dividend Announcement
The company also recently disclosed a monthly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 17th will be issued a $0.04 dividend. This represents a $0.48 annualized dividend and a dividend yield of 4.16%. The ex-dividend date is Friday, February 28th. Extendicare’s payout ratio is currently 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- How to Use the MarketBeat Stock Screener
- February’s Top 3 Stock Upgrades: What Investors Need to Know
- How to Use Stock Screeners to Find Stocks
- 2 Safe-Haven Stocks Shielded From Import Tariffs
- Technology Stocks Explained: Here’s What to Know About Tech
- Nebius Group: A Strategic Entry Point for Investors?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.